Denise S. K. Brookes, Julie N. Briody, Craig F. Munns, Peter S. W

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Comparative bone status assessment by dual energy X-ray absorptiometry, peripheral quantitative computed tomography and quantitative ultrasound in adolescents.
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
Poor growth in an infant with cystic fibrosis due to an antenatal perforation and incomplete bowel obstruction  Isobel Brookes, Maya Desai, Gillian Duthie,
The prevalence of “risky behaviour” in adults with cystic fibrosis
Cystic Fibrosis Foundation and European Cystic Fibrosis Society Survey of cystic fibrosis mental health care delivery  J. Abbott, J.S. Elborn, A.M. Georgiopoulos,
Multiple prevalent fractures in relation to macroscopic bone architecture in patients with cystic fibrosis  Mirjam Stahl, Christian Holfelder, Carolin.
Cystic fibrosis-related bone disease in children: Examination of peripheral quantitative computed tomography (pQCT) data  Denise S.K. Brookes, Julie N.
Development, validation, and implementation of a questionnaire assessing disease knowledge and understanding in adult cystic fibrosis patients  Karen.
Comparative bone status assessment by dual energy X-ray absorptiometry, peripheral quantitative computed tomography and quantitative ultrasound in adolescents.
Abaigeal D. Jackson, Christopher H. Goss  Journal of Cystic Fibrosis 
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
Avani C. Modi, Crystal S. Lim, Nami Yu, David Geller, Mary H
Melissa S. Putman, Joshua F
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Laura Viviani, Baroukh M. Assael, Eitan Kerem 
Cirrhosis and other liver disease in cystic fibrosis
Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin 
Rate of improvement of CF life expectancy exceeds that of general population— Observational death registration study  Matthew N. Hurley, Tricia M. McKeever,
The application of current lifetable methods to compare cystic fibrosis median survival internationally is limited  Abaigeal D. Jackson, Leslie Daly,
Controlled clinical trials in cystic fibrosis — are we doing better?
Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Cystic fibrosis mortality trend in Italy from 1970 to 2011
Long-term daily high and low doses of azithromycin in children with cystic fibrosis: A randomized controlled trial  S.K. Kabra, R. Pawaiya, Rakesh Lodha,
Amyloidosis in cystic fibrosis: A case series
Ghrelin and leptin levels in young adults with cystic fibrosis: Relationship with body fat  Charilaos Stylianou, Assimina Galli-Tsinopoulou, George Koliakos,
Asians with cystic fibrosis in the UK have worse disease outcomes than clinic matched white homozygous ΔF508 controls  Jonathan McCormick, Simon A. Ogston,
A.H. Gifford  Journal of Cystic Fibrosis 
Lung deposition of inhaled tobramycin with eFlow rapid/LC Plus jet nebuliser in healthy and cystic fibrosis subjects  Warren Lenney, Frank Edenborough,
Demographics of glucose metabolism in cystic fibrosis
M. Al-Aloul, M. Jackson, G. Bell, M. Ledson, M. Walshaw 
Antonia V. Bennett, Donald L. Patrick, James F. Lymp, Todd C
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Ultrasound and magnetic resonance imaging assessment of joint disease in symptomatic patients with cystic fibrosis arthropathy  G. Fitch, K. Williams,
Sally H. Pattison, Geraint B. Rogers, Martin Crockard, J
Cytokine gene polymorphisms and severity of CF lung disease
Stenotrophomonas maltophilia in cystic fibrosis: Improved detection by the use of selective agar and evaluation of antimicrobial resistance  P. Goncalves-Vidigal,
Nasal polyposis in lung transplant recipients with cystic fibrosis
Elliott C. Dasenbrook, Gregory S. Sawicki  Journal of Cystic Fibrosis 
Chee Y. Ooi, Peter R. Durie  Journal of Cystic Fibrosis 
D.Y.F. Mak, J. Sykes, A.L. Stephenson, L.C. Lands 
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic  Amanda L. Griffiths, Danielle F. Wurzel,
Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire  Joän M. Patterson, Melanie Wall, Jerica.
Segregation of children with CF diagnosed via newborn screening and acquisition of Pseudomonas aeruginosa  Karen O. McKay, Peter J. Cooper, Peter P. van.
Disease disclosure in individuals with cystic fibrosis: Association with psychosocial and health outcomes  Adrienne P. Borschuk, Robin S. Everhart, Michelle.
Higher risk of hospitalization among females with cystic fibrosis
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
V. Thompson, N. Mayer-Hamblett, M. Kloster, D. Bilton, P.A. Flume 
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
Daniel J. Smith, Gregory J. Anderson, Scott C. Bell, David W. Reid 
Serum-surfactant SP-D correlates inversely to lung function in cystic fibrosis  Hanne Vebert Olesen, Uffe Holmskov, Peter Oluf Schiøtz, Grith Lykke Sørensen 
D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher 
Gut dysbiosis in cystic fibrosis
CFTR modulators and pregnancy: Our work has only just begun
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
Beta-lactam allergy in adults with cystic fibrosis
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Improved early diagnosis of Pseudomonas aeruginosa by real-time PCR to prevent chronic colonisation in a paediatric cystic fibrosis population  Elaine.
Cystic fibrosis and pregnancy in the modern era: A case control study
Respiratory physicians and clinic coordinators' attitudes to population-based cystic fibrosis carrier screening  Fiona Cunningham, Sharon Lewis, Lisette.
Wolfgang Högler, Craig F Munns  The Lancet Global Health 
Presentation transcript:

Cystic fibrosis-related bone disease explored using a four step algorithm  Denise S.K. Brookes, Julie N. Briody, Craig F. Munns, Peter S.W. Davies, Rebecca J. Hill  Journal of Cystic Fibrosis  Volume 14, Issue 1, Pages 127-134 (January 2015) DOI: 10.1016/j.jcf.2014.07.011 Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

Fig. 1 The guidelines of the 4 step algorithm interpretation for DXA. Firstly, the procedure assesses height and total body BMC for age. Thereafter, participants are classified as “low total body BMC considered for height” and are further assessed for LTM for height and total body BMC for LTM. Combining steps 3 and 4 concludes a possible biomechanical pathogenesis of a CF-related bone disease. Adapted from Hogler et al. [12] with permission. Journal of Cystic Fibrosis 2015 14, 127-134DOI: (10.1016/j.jcf.2014.07.011) Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

Fig. 2 Total body Z-scores for each CF genotype category: (A) BMD as a group (homozygous: n=31; heterozygous: n=18; absent: n=4); (B) bone mineral content (BMC) as a group, and (C) BMC by sex (homozygous: n=19 F/12 M; heterozygous: n=13 F/5 M; absent: n=2 F/2 M). Mean±SD, *p<0.05. Journal of Cystic Fibrosis 2015 14, 127-134DOI: (10.1016/j.jcf.2014.07.011) Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions